Global Oncology/Cancer Drugs Sales Market Report 2021

1 Oncology/Cancer Drugs Market Overview

• 1.1 Oncology/Cancer Drugs Product Scope
• 1.2 Oncology/Cancer Drugs Segment by Type
  • 1.2.1 Global Oncology/Cancer Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Antimetabolite
  • 1.2.3 Alkaloid drugs
  • 1.2.4 Hormone
  • 1.2.5 Targeted drug
  • 1.2.6 Platinum-based drugs
  • 1.2.7 Other
• 1.3 Oncology/Cancer Drugs Segment by Application
  • 1.3.1 Global Oncology/Cancer Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Respiratory/Lung Cancer
  • 1.3.7 Other
• 1.4 Oncology/Cancer Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Oncology/Cancer Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Oncology/Cancer Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Oncology/Cancer Drugs Price Trends (2016-2027)

2 Oncology/Cancer Drugs Estimates and Forecasts by Region

• 2.1 Global Oncology/Cancer Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Oncology/Cancer Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Oncology/Cancer Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Oncology/Cancer Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Oncology/Cancer Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Oncology/Cancer Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Oncology/Cancer Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Oncology/Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Oncology/Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Oncology/Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Oncology/Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Oncology/Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Oncology/Cancer Drugs Estimates and Projections (2016-2027)

3 Global Oncology/Cancer Drugs Competition Landscape by Players

• 3.1 Global Top Oncology/Cancer Drugs Players by Sales (2016-2021)
• 3.2 Global Top Oncology/Cancer Drugs Players by Revenue (2016-2021)
• 3.3 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology/Cancer Drugs as of 2020)
• 3.4 Global Oncology/Cancer Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Oncology/Cancer Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Oncology/Cancer Drugs Market Size by Type

• 4.1 Global Oncology/Cancer Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Oncology/Cancer Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Oncology/Cancer Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Oncology/Cancer Drugs Price by Type (2016-2021)
• 4.2 Global Oncology/Cancer Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Oncology/Cancer Drugs Price Forecast by Type (2022-2027)

5 Global Oncology/Cancer Drugs Market Size by Application

• 5.1 Global Oncology/Cancer Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Oncology/Cancer Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Oncology/Cancer Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Oncology/Cancer Drugs Price by Application (2016-2021)
• 5.2 Global Oncology/Cancer Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Oncology/Cancer Drugs Price Forecast by Application (2022-2027)

6 North America Oncology/Cancer Drugs Market Facts & Figures

• 6.1 North America Oncology/Cancer Drugs Sales by Company
  • 6.1.1 North America Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 6.2 North America Oncology/Cancer Drugs Sales Breakdown by Type
  • 6.2.1 North America Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Oncology/Cancer Drugs Sales Breakdown by Application
  • 6.3.1 North America Oncology/Cancer Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Oncology/Cancer Drugs Sales Breakdown by Application (2022-2027)

7 Europe Oncology/Cancer Drugs Market Facts & Figures

• 7.1 Europe Oncology/Cancer Drugs Sales by Company
  • 7.1.1 Europe Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 7.2 Europe Oncology/Cancer Drugs Sales Breakdown by Type
  • 7.2.1 Europe Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Oncology/Cancer Drugs Sales Breakdown by Application
  • 7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Oncology/Cancer Drugs Market Facts & Figures

• 8.1 China Oncology/Cancer Drugs Sales by Company
  • 8.1.1 China Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 8.1.2 China Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 8.2 China Oncology/Cancer Drugs Sales Breakdown by Type
  • 8.2.1 China Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Oncology/Cancer Drugs Sales Breakdown by Application
  • 8.3.1 China 153 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 153 Sales Breakdown by Application (2022-2027)

9 Japan Oncology/Cancer Drugs Market Facts & Figures

• 9.1 Japan Oncology/Cancer Drugs Sales by Company
  • 9.1.1 Japan Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 9.2 Japan Oncology/Cancer Drugs Sales Breakdown by Type
  • 9.2.1 Japan Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Oncology/Cancer Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Oncology/Cancer Drugs Market Facts & Figures

• 10.1 Southeast Asia Oncology/Cancer Drugs Sales by Company
  • 10.1.1 Southeast Asia Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Oncology/Cancer Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Oncology/Cancer Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Oncology/Cancer Drugs Market Facts & Figures

• 11.1 India Oncology/Cancer Drugs Sales by Company
  • 11.1.1 India Oncology/Cancer Drugs Sales by Company (2016-2021)
  • 11.1.2 India Oncology/Cancer Drugs Revenue by Company (2016-2021)
• 11.2 India Oncology/Cancer Drugs Sales Breakdown by Type
  • 11.2.1 India Oncology/Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Oncology/Cancer Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Oncology/Cancer Drugs Sales Breakdown by Application
  • 11.3.1 India Oncology/Cancer Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Oncology/Cancer Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Oncology/Cancer Drugs Business

• 12.1 Roche
  • 12.1.1 Roche Corporation Information
  • 12.1.2 Roche Business Overview
  • 12.1.3 Roche Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Roche Oncology/Cancer Drugs Products Offered
  • 12.1.5 Roche Recent Development
• 12.2 HENGRUI
  • 12.2.1 HENGRUI Corporation Information
  • 12.2.2 HENGRUI Business Overview
  • 12.2.3 HENGRUI Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 HENGRUI Oncology/Cancer Drugs Products Offered
  • 12.2.5 HENGRUI Recent Development
• 12.3 AstraZeneca
  • 12.3.1 AstraZeneca Corporation Information
  • 12.3.2 AstraZeneca Business Overview
  • 12.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 AstraZeneca Oncology/Cancer Drugs Products Offered
  • 12.3.5 AstraZeneca Recent Development
• 12.4 QILU
  • 12.4.1 QILU Corporation Information
  • 12.4.2 QILU Business Overview
  • 12.4.3 QILU Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 QILU Oncology/Cancer Drugs Products Offered
  • 12.4.5 QILU Recent Development
• 12.5 Sanofi
  • 12.5.1 Sanofi Corporation Information
  • 12.5.2 Sanofi Business Overview
  • 12.5.3 Sanofi Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Sanofi Oncology/Cancer Drugs Products Offered
  • 12.5.5 Sanofi Recent Development
• 12.6 HANSOH
  • 12.6.1 HANSOH Corporation Information
  • 12.6.2 HANSOH Business Overview
  • 12.6.3 HANSOH Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 HANSOH Oncology/Cancer Drugs Products Offered
  • 12.6.5 HANSOH Recent Development
• 12.7 LUYE
  • 12.7.1 LUYE Corporation Information
  • 12.7.2 LUYE Business Overview
  • 12.7.3 LUYE Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 LUYE Oncology/Cancer Drugs Products Offered
  • 12.7.5 LUYE Recent Development
• 12.8 Novartis
  • 12.8.1 Novartis Corporation Information
  • 12.8.2 Novartis Business Overview
  • 12.8.3 Novartis Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Novartis Oncology/Cancer Drugs Products Offered
  • 12.8.5 Novartis Recent Development
• 12.9 GuiZhou YiBai
  • 12.9.1 GuiZhou YiBai Corporation Information
  • 12.9.2 GuiZhou YiBai Business Overview
  • 12.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 GuiZhou YiBai Oncology/Cancer Drugs Products Offered
  • 12.9.5 GuiZhou YiBai Recent Development
• 12.10 Lunan
  • 12.10.1 Lunan Corporation Information
  • 12.10.2 Lunan Business Overview
  • 12.10.3 Lunan Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Lunan Oncology/Cancer Drugs Products Offered
  • 12.10.5 Lunan Recent Development
• 12.11 Eli Lilly and Company
  • 12.11.1 Eli Lilly and Company Corporation Information
  • 12.11.2 Eli Lilly and Company Business Overview
  • 12.11.3 Eli Lilly and Company Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Eli Lilly and Company Oncology/Cancer Drugs Products Offered
  • 12.11.5 Eli Lilly and Company Recent Development

13 Oncology/Cancer Drugs Manufacturing Cost Analysis

• 13.1 Oncology/Cancer Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Oncology/Cancer Drugs
• 13.4 Oncology/Cancer Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Oncology/Cancer Drugs Distributors List
• 14.3 Oncology/Cancer Drugs Customers

15 Market Dynamics

• 15.1 Oncology/Cancer Drugs Market Trends
• 15.2 Oncology/Cancer Drugs Drivers
• 15.3 Oncology/Cancer Drugs Market Challenges
• 15.4 Oncology/Cancer Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List